US1858991011 - Common Stock

We assign a fundamental rating of **4** out of 10 to **CLF**. **CLF** was compared to 157 industry peers in the **Metals & Mining** industry. Both the profitability and the financial health of **CLF** get a neutral evaluation. Nothing too spectacular is happening here. **CLF** is not valued too expensively and it also shows a decent growth rate.

Of the past 5 years **CLF** 4 years were profitable.

With a **Return On Assets** value of **0.26%**, **CLF** perfoms like the industry average, outperforming **56.05%** of the companies in the same industry.

With a **Return On Invested Capital** value of **2.84%**, **CLF** perfoms like the industry average, outperforming **52.23%** of the companies in the same industry.

Measured over the past 3 years, the **Average Return On Invested Capital** for **CLF** is above the industry average of **8.67%**.

The 3 year average ROIC (**11.26%**) for **CLF** is well above the current ROIC(**2.84%**). The reason for the recent decline needs to be investigated.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.26% | ||

ROE | 0.62% | ||

ROIC | 2.84% |

ROA(3y)8.38%

ROA(5y)6.55%

ROE(3y)25.54%

ROE(5y)30.81%

ROIC(3y)11.26%

ROIC(5y)9.09%

In the last couple of years the **Profit Margin** of **CLF** has declined.

In the last couple of years the **Operating Margin** of **CLF** has declined.

The **Gross Margin** of **CLF** (**5.21%**) is worse than **63.69%** of its industry peers.

In the last couple of years the **Gross Margin** of **CLF** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 2.43% | ||

PM (TTM) | 0.21% | ||

GM | 5.21% |

OM growth 3Y3.41%

OM growth 5Y-34.19%

PM growth 3YN/A

PM growth 5Y-48.14%

GM growth 3Y-10.8%

GM growth 5Y-28.89%

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), **CLF** is creating some value.

Compared to 1 year ago, **CLF** has less shares outstanding

The number of shares outstanding for **CLF** has been increased compared to 5 years ago.

The debt/assets ratio for **CLF** has been reduced compared to a year ago.

The **Altman-Z score** of **CLF** (**2.05**) is comparable to the rest of the industry.

The Debt to FCF ratio of **CLF** is **2.48**, which is a good value as it means it would take **CLF**, **2.48** years of fcf income to pay off all of its debts.

Looking at the **Debt to FCF ratio**, with a value of **2.48**, **CLF** is in the better half of the industry, outperforming **75.80%** of the companies in the same industry.

Although **CLF** does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.49 | ||

Debt/FCF | 2.48 | ||

Altman-Z | 2.05 |

ROIC/WACC0.35

WACC8.11%

A Current Ratio of **1.87** indicates that **CLF** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.87 | ||

Quick Ratio | 0.6 |

The earnings per share for **CLF** have been decreasing by **-19.03%** on average. This is quite bad

The **Revenue** has decreased by **-4.40%** in the past year.

The **Revenue** has been growing by **56.65%** on average over the past years. This is a very strong growth!

EPS 1Y (TTM)47.73%

EPS 3YN/A

EPS 5Y-19.03%

EPS Q2Q%-100%

Revenue 1Y (TTM)-4.4%

Revenue growth 3Y60.16%

Revenue growth 5Y56.65%

Sales Q2Q%-14.91%

The **Earnings Per Share** is expected to grow by **15.45%** on average over the next years. This is quite good.

EPS Next Y-108.83%

EPS Next 2Y-2.12%

EPS Next 3Y15.45%

EPS Next 5YN/A

Revenue Next Year-7.22%

Revenue Next 2Y-3.34%

Revenue Next 3Y-1.57%

Revenue Next 5Y-0.78%

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

A **Price/Earnings** ratio of **19.43** indicates a rather expensive valuation of **CLF**.

Based on the **Price/Forward Earnings** ratio of **12.80**, the valuation of **CLF** can be described as correct.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 19.43 | ||

Fwd PE | 12.8 |

100.00% of the companies in the same industry are more expensive than **CLF**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 4.25 | ||

EV/EBITDA | 6.45 |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-2.12%

EPS Next 3Y15.45%

No dividends for **CLF**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**CLEVELAND-CLIFFS INC**

NYSE:CLF (8/15/2024, 5:30:00 PM)

After market: 12.65 +0.02 (+0.16%)**12.63**

**+0.08 (+0.64%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap6.01B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 19.43 | ||

Fwd PE | 12.8 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.26% | ||

ROE | 0.62% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 2.43% | ||

PM (TTM) | 0.21% | ||

GM | 5.21% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1.24

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.49 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.87 | ||

Quick Ratio | 0.6 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)47.73%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-108.83%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-4.4%

Revenue growth 3Y60.16%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y